Clinical Trials Browser

Phase 2 × Medroxyprogesterone × Clear all

NCT00577122 2023-10-16

Medroxyprogesterone +/- Cyclophosphamide & Methotrexate in Hormone Receptor-Negative Recurrent/Metastatic Breast Cancer

Phase 2 Completed

30 enrolled 13 charts

Breast Neoplasms

NCT00064025 2016-04-11

Medroxyprogesterone in Treating Patients With Endometrioid Adenocarcinoma of the Uterine Corpus

Phase 2 Completed

75 enrolled 6 charts

Endometrial Adenocarcinoma

NCT00003179 2013-06-10

Surgery Plus Medroxyprogesterone in Preventing Endometrial Cancer

Phase 2 Terminated

Endometrial Neoplasms